+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Horizon Pharma plc - logo

Horizon Pharma plc is a biopharmaceutical company focused on developing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases. The company markets 11 medicines through its orphan, rheumatology and primary care business units, including ACTIMMUNE, BUPHENYL, DUEXIS, RAVICTI, QUINSAIR and PENNSAID. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.

Lysosomal Storage Diseases Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Lysosomal Storage Diseases Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 95 Pages
  • Global
From
Contract Dose Manufacturing Industry by the Numbers - Composition, Size, Market Share and Outlook - 2020 Edition - Product Thumbnail Image

Contract Dose Manufacturing Industry by the Numbers - Composition, Size, Market Share and Outlook - 2020 Edition

  • Report
  • October 2020
  • 49 Pages
  • Global
From
Loading Indicator